Biohaven Pharmaceutical Holding Co. Ltd.
(NYSE : BHVN)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.31%165.690.7%$1175.46m
PFEPfizer Inc. 1.42%37.070.9%$1154.26m
LLYEli Lilly & Co. 2.41%211.111.1%$956.27m
ABBVAbbVie, Inc. -0.22%110.621.9%$730.56m
BMYBristol-Myers Squibb Co. 0.19%64.681.0%$680.46m
MRKMerck & Co., Inc. 0.06%81.030.7%$678.46m
AZNAstraZeneca Plc 1.00%53.781.2%$676.41m
ARCTArcturus Therapeutics Holdings, Inc. 1.68%68.840.0%$233.85m
VTRSViatris, Inc. -1.49%17.170.0%$190.67m
GRTSGritstone Oncology, Inc. -10.92%24.150.0%$188.00m
NVSNovartis AG 1.26%98.120.2%$176.16m
RPRXRoyalty Pharma Plc 0.80%51.570.2%$175.66m
GSKGlaxoSmithKline Plc 1.36%38.880.2%$156.51m
SNYSanofi -0.42%49.480.2%$134.41m
RGENRepligen Corp. -1.46%216.126.9%$77.25m

Company Profile

Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.